PureTech Health plc (LON:PRTC – Get Free Report)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 140.13 ($1.81) and traded as high as GBX 142.20 ($1.83). PureTech Health shares last traded at GBX 138.80 ($1.79), with a volume of 544,139 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 455 ($5.87) price target on shares of PureTech Health in a report on Monday, December 16th.
Get Our Latest Research Report on PRTC
PureTech Health Price Performance
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Articles
- Five stocks we like better than PureTech Health
- How to Most Effectively Use the MarketBeat Earnings Screener
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Investing in Travel Stocks Benefits
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Find and Profitably Trade Stocks at 52-Week Lows
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.